Skip to main content
Smart Investors Daily
Becton, Dickinson and Company logo

NASDAQ · BDX

Becton, Dickinson and Company

Healthcare · Medical - Instruments & Supplies

$212.68

Down-$3.40 (-1.57%)

Updated Nov 20, 2026, 2:27 AM

SID Score

6.8/10

Composite research score

Smart Money

58/100

Neutral

Market cap
57.44B
P/E ratio
34.23
Dividend yield
1.96%
52-week range
$140.11 – $220.36
Volume
2.57M
Avg. volume
1.98M

Price performance · BDX

BDX price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 19, 2026

BDX closed at $212.68 after 21 trading sessions, up 6.12% for the selected period.

Last close
$212.68
Period change
+6.12%
Period low
$195.03
Period high
$218.03
Daily close
View OHLC price history
BDX OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 19, 2026$215.23$216.375$211.5401$212.682.57M
Nov 18, 2026$212.82$216.96$212.755$216.081.32M
Nov 17, 2026$215.035$216.9805$214.05$215.422.31M
Nov 16, 2026$219.45$220.36$215.64$216.471.5M
Nov 13, 2026$217.23$219.78$216.3829$218.031.88M
Nov 12, 2026$215.675$216.85$213.335$215.711.76M
Nov 11, 2026$210.06$214.88$209.00$214.521.64M
Nov 10, 2026$213.93$215.25$211.70$212.611.79M
Nov 9, 2026$213.02$216.735$211.13$215.252.04M
Nov 6, 2026$209.29$214.88$208.95$211.882.17M
Nov 5, 2026$208.00$214.78$206.50$213.553.99M
Nov 4, 2026$203.00$209.835$200.30$209.194.46M
Nov 3, 2026$197.16$199.172$196.24$198.171.96M
Nov 2, 2026$197.52$199.92$197.225$198.601.79M
Oct 30, 2026$199.77$199.94$197.06$197.882.92M
Oct 29, 2026$197.11$198.64$194.53$198.342.2M
Oct 28, 2026$194.22$196.88$193.80$195.161.74M
Oct 27, 2026$194.77$196.16$194.095$195.031.15M
Oct 26, 2026$198.13$198.90$194.71$196.391.64M
Oct 23, 2026$199.18$200.42$197.15$198.911.3M
Oct 22, 2026$195.35$200.47$194.91$200.421.38M

Latest BDX news

The latest Smart Investors Daily articles mentioning BDX.

BDX research

Overview

Company profile and research snapshot.

Company profile

Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$210.00
Implied upside
—
Analysts
15
BDX recent ratings
DateFirmRatingTarget
Nov 10, 2026BarclaysUnderweight—
Nov 6, 2026RBC CapitalSector Perform—
Nov 6, 2026Evercore ISI GroupOutperform—
Nov 6, 2026Piper SandlerNeutral—
Nov 6, 2026Wells FargoOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 10, 2026

BD to Host Investor Day on December 10, 2026

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will host an Investor Day for institutional investors and financial analysts on Thursday, December 10, 2026, in New York, NY. Registration will open at 7:30 a.m. ET, and the program will begin at 8:30 a.m. ET.

Yahoo · Nov 9, 2026

Wells Fargo Doesn’t Think Becton Dickinson (BDX) Is Done Skyrocketing

We just published a list of the Don’t Miss Out: 10 Stocks Getting Major Upgrades From Top Analysts and Becton Dickinson (NYSE:BDX) ranked 10th on this list. Wall Street ended a punishing week on Friday with a partial recovery. The Nasdaq Composite rose 1.09% to 24,579.42 and the S&P 500 gained 0.31% to 7,376.86, while […]

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.